427 related articles for article (PubMed ID: 27102200)
1. Alcohol-related breast cancer in postmenopausal women - effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex-hormone levels and interaction with alcohol consumption and NSAID usage in a nested case-control study and a randomised controlled trial.
Kopp TI; Jensen DM; Ravn-Haren G; Cohen A; Sommer HM; Dragsted LO; Tjonneland A; Hougaard DM; Vogel U
BMC Cancer; 2016 Apr; 16():283. PubMed ID: 27102200
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
Dunning AM; Dowsett M; Healey CS; Tee L; Luben RN; Folkerd E; Novik KL; Kelemen L; Ogata S; Pharoah PD; Easton DF; Day NE; Ponder BA
J Natl Cancer Inst; 2004 Jun; 96(12):936-45. PubMed ID: 15199113
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes.
Vogel U; Christensen J; Nexø BA; Wallin H; Friis S; Tjønneland A
Carcinogenesis; 2007 Feb; 28(2):427-34. PubMed ID: 16959787
[TBL] [Abstract][Full Text] [Related]
4. Association between CYP19A1 polymorphisms and sex hormones in postmenopausal Japanese women.
Kidokoro K; Ino K; Hirose K; Kajiyama H; Hosono S; Suzuki T; Kawase T; Hiraki A; Hamajima N; Tanaka H; Tajima K; Kikkawa F; Matsuo K
J Hum Genet; 2009 Feb; 54(2):78-85. PubMed ID: 19158807
[TBL] [Abstract][Full Text] [Related]
5. Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole.
Lunardi G; Piccioli P; Bruzzi P; Notaro R; Lastraioli S; Serra M; Marroni P; Bighin C; Mansutti M; Puglisi F; Porpiglia M; Ponzone R; Bisagni G; Garrone O; Cavazzini G; Clavarezza M; Del Mastro L
Breast Cancer Res Treat; 2013 Jan; 137(1):167-74. PubMed ID: 23129173
[TBL] [Abstract][Full Text] [Related]
6. PPARgamma-PGC-1alpha activity is determinant of alcohol related breast cancer.
Petersen RK; Larsen SB; Jensen DM; Christensen J; Olsen A; Loft S; Nellemann C; Overvad K; Kristiansen K; Tjønneland A; Vogel U
Cancer Lett; 2012 Feb; 315(1):59-68. PubMed ID: 22050908
[TBL] [Abstract][Full Text] [Related]
7. Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women.
Warren R; Skinner J; Sala E; Denton E; Dowsett M; Folkerd E; Healey CS; Dunning A; Doody D; Ponder B; Luben RN; Day NE; Easton D
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1502-8. PubMed ID: 16896040
[TBL] [Abstract][Full Text] [Related]
8. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L
Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
[TBL] [Abstract][Full Text] [Related]
9. Alcohol drinking, ADH1B and ADH1C genotypes and the risk of postmenopausal breast cancer by hormone receptor status: the Netherlands Cohort Study on diet and cancer.
Hahn M; Simons CCJM; Weijenberg MP; van den Brandt PA
Carcinogenesis; 2018 Dec; 39(11):1342-1351. PubMed ID: 30052783
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of the effect of alcohol consumption and ADH3 genotype on plasma steroid hormone levels and breast cancer risk.
Hines LM; Hankinson SE; Smith-Warner SA; Spiegelman D; Kelsey KT; Colditz GA; Willett WC; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1099-105. PubMed ID: 11045794
[TBL] [Abstract][Full Text] [Related]
11. S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.
Shao X; Cai J; Zheng Y; Wang J; Feng J; Huang Y; Shi L; Chen Z; Guo Y; Wang X
Int J Clin Exp Pathol; 2015; 8(5):5309-17. PubMed ID: 26191232
[TBL] [Abstract][Full Text] [Related]
12. PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose level.
Zhu L; Huang Q; Xie Z; Kang M; Ding H; Chen B; Chen Y; Liu C; Wang Y; Tang W
Oncotarget; 2017 Jun; 8(23):37308-37320. PubMed ID: 28418876
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
[TBL] [Abstract][Full Text] [Related]
14. Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial.
Fontein DB; Houtsma D; Nortier JW; Baak-Pablo RF; Kranenbarg EM; van der Straaten TR; Putter H; Seynaeve C; Gelderblom H; van de Velde CJ; Guchelaar HJ
Breast Cancer Res Treat; 2014 Apr; 144(3):599-606. PubMed ID: 24590773
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer.
Johansson H; Aristarco V; Gandini S; Gjerde J; Macis D; Guerrieri-Gonzaga A; Serrano D; Lazzeroni M; Rajasekaran A; Williard CV; Mellgren G; DeCensi A; Bonanni B
Pharmacogenomics J; 2020 Feb; 20(1):19-26. PubMed ID: 30967597
[TBL] [Abstract][Full Text] [Related]
16. CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
Leyland-Jones B; Gray KP; Abramovitz M; Bouzyk M; Young B; Long B; Kammler R; Dell'Orto P; Biasi MO; Thürlimann B; Lyng MB; Ditzel HJ; Harvey VJ; Neven P; Treilleux I; Rasmussen BB; Maibach R; Price KN; Coates AS; Goldhirsch A; Pagani O; Viale G; Rae JM; Regan MM
Breast Cancer Res Treat; 2015 Jun; 151(2):373-84. PubMed ID: 25935582
[TBL] [Abstract][Full Text] [Related]
17. Alcohol and endogenous sex steroid levels in postmenopausal women: a cross-sectional study.
Onland-Moret NC; Peeters PH; van der Schouw YT; Grobbee DE; van Gils CH
J Clin Endocrinol Metab; 2005 Mar; 90(3):1414-9. PubMed ID: 15572431
[TBL] [Abstract][Full Text] [Related]
18. Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women.
Cai H; Shu XO; Egan KM; Cai Q; Long JR; Gao YT; Zheng W
Pharmacogenet Genomics; 2008 Aug; 18(8):657-64. PubMed ID: 18622258
[TBL] [Abstract][Full Text] [Related]
19. Mediation analysis of the alcohol-postmenopausal breast cancer relationship by sex hormones in the EPIC cohort.
Assi N; Rinaldi S; Viallon V; Dashti SG; Dossus L; Fournier A; Cervenka I; Kvaskoff M; Turzanski-Fortner R; Bergmann M; Boeing H; Panico S; Ricceri F; Palli D; Tumino R; Grioni S; Sánchez Pérez MJ; Chirlaque MD; Bonet C; Gurrea AB; Amiano Etxezarreta P; Merino S; Bueno de Mesquita HB; van Gils CH; Onland-Moret C; Tjønneland A; Overvad K; Trichopoulou A; Martimianaki G; Karakatsani A; Key T; Christakoudi S; Ellingjord-Dale M; Tsilidis K; Riboli E; Kaaks R; Gunter MJ; Ferrari P
Int J Cancer; 2020 Feb; 146(3):759-768. PubMed ID: 30968961
[TBL] [Abstract][Full Text] [Related]
20. PPARgamma Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes.
Vogel U; Segel S; Dethlefsen C; Tjønneland A; Saber AT; Wallin H; Jensen MK; Schmidt EB; Andersen PS; Overvad K
BMC Med Genet; 2009 Jun; 10():52. PubMed ID: 19500413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
